$BTCS stock is up 23% today. Here's what we see in our data.

$BTCS stock has now risen 23% today, according to our price data from Polygon. There has been approximately $3,765,680 of trading volume.

$BTCS Insider Trading Activity

$BTCS insiders have traded $BTCS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $BTCS stock by insiders over the last 6 months:

• CHARLES W ALLEN (CEO) has made 0 purchases and 3 sales selling 200,000 shares for an estimated $282,539.
• MELANIE PUMP sold 22,000 shares for an estimated $76,780

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BTCS Hedge Fund Activity

We have seen 13 institutional investors add shares of $BTCS stock to their portfolio, and 10 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INVESCO LTD. added 118,976 shares (+inf%) to their portfolio in Q4 2024, for an estimated $293,870
• RENAISSANCE TECHNOLOGIES LLC added 90,171 shares (+242.3%) to their portfolio in Q4 2024, for an estimated $222,722
• CITADEL ADVISORS LLC removed 43,900 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $108,433
• VANGUARD GROUP INC added 40,686 shares (+11.1%) to their portfolio in Q4 2024, for an estimated $100,494
• HERON BAY CAPITAL MANAGEMENT removed 32,053 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $79,170
• VIRTU FINANCIAL LLC removed 23,458 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $57,941
• XTX TOPCO LTD removed 17,257 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $42,624

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $BTCS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.